Meeting
2017 ASCO Annual Meeting
Comprehensive assessment of ATRX mutation, protein expression, and alternative lengthening of telomeres (ALT) phenotype in grade II and III gliomas.
Authors
Aline P. Becker
The Ohio State University, Columbus, OH
Aline P. Becker , Erica Hlavin Bell , Jessica Fleming , Joseph P McElroy , Denise Fabian , Sasha Beyer , Andrea L Salavaggione , Mindy K Graham , Christopher M Heaphy , Oliver Oehlke , Ori Staszewski , Marco Prinz , Anca Grosu , Arnab Chakravarti
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Central Nervous System Tumors
Track
Central Nervous System Tumors
Sub Track
Central Nervous System Tumors
Citation
J Clin Oncol 35, 2017 (suppl; abstr 2064)
DOI
10.1200/JCO.2017.35.15_suppl.2064
Abstract #
2064
Poster Bd #
306
Abstract Disclosures
Similar Posters
Poster
2015 ASCO Annual Meeting
Analysis of BRAF alterations and molecular profiling in glioblastoma and astrocytoma .
First Author: Nadia Faiq
Poster
2023 ASCO Annual Meeting
Vulnerability to immune therapy in BRAF- and MYB-altered pediatric gliomas.
First Author: Michael DeCuypere
Poster
2023 ASCO Annual Meeting
New ESMO scale for clinical actionability of molecular targets (ESCAT) for gliomas based on a multicentric real world data cohort using next-generation sequencing (NGS).
First Author: Oriol Mirallas
Poster
2020 ASCO Virtual Scientific Program
Comprehensive gene expression analysis of IDH1/2 mutant biliary cancers (BC).
First Author: Francesca Battaglin